Document Detail


The effect of curcumin on lipid level in patients with acute coronary syndrome.
MedLine Citation:
PMID:  19151449     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: to evaluate the effects of curcumin on total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride in acute coronary syndrome patients. METHODS: this study were conducted at Dr. Cipto Mangunkusumo General Hospital (RSUPN-CM), Persahabatan Hospital, MMC Hospital and Medistra Hospital, Jakarta. The study started from 1 May 2005 to 5 May 2006. Study Design was an interventional study which was a randomized double blind controlled trial to evaluate the effects of curcumin administration at escalating doses (low dose 3 times 15 mg/day, moderate dose 3 times 30 mg/day, and high dose 3 times 60 mg/day) on total cholesterol level, LDL cholesterol level, HDL cholesterol level, and triglyceride level in ACS patients. RESULTS: a 75 ACS patients undergoing randomization participated in randomized controlled trial (RCT). Of the 75 ACS patients participating in that RCT, 67 received care at RSCM, 6 at Persahabatan Hospital, and 2 at MMC Hospital. As many as 63 patients were able to participate in the RCT up to its conclusion. There was no significant difference in age, sex, risk factor of dyslipidemia, DM, smoking, hypertension, CHD history in family, height, body weight and body mass index, waist circumference, systolic blood pressure, diastolic blood pressure in the four groups of patients. This showed that the randomization performed was reasonably good. There was no significant difference in laboratory parameters, such as total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride, fasting blood glucose, blood glucose 2 hours PP, glyco Hb, triglyceride, Hb, Ht, leukocyte, thrombocyte, ureum, creatinine, SGOT, SGPT, in the four groups. There was no significant difference in types of ACS and locations of ACS in the four groups as well. There was no significant difference in statin medicatios (simvastatin), aspirin ACE inhibitor, and DM medications in the four groups. No patient used tiazolidindion. No significant difference was found in the percentage of compliance in the four groups of patients. The effects of curcumin on total cholesterol level and LDL cholesterol level, there was a trend that the lower the dose of curcumin, the higher the effect of reduction. For HDL cholesterol level, there was also a trend that the lower the dose of curcumin, the higher the effect of increase in HDL cholesterol level. However, for triglyceride the pattern was not the same, and the group of moderate-dose curcumin shoed the minimal effect of increase, followed by the low-dose curcumin and finally the high-dose curcumin that showed the highest effect of increase. CONCLUSION: the administration of low-dose curcumin showed a trend of reduction in total cholesterol level and LDL cholesterol level in ACS patients.
Authors:
Idrus Alwi; Teguh Santoso; Slamet Suyono; Bambang Sutrisna; Frans D Suyatna; Siti Boedina Kresno; Sri Ernie
Related Documents :
16295049 - Glycemic optimization may reduce lipid peroxidation independent of weight and blood lip...
1718369 - Does dietary magnesium modulate blood lipids?
19662759 - Dyslipidemia and adherence to the mediterranean diet in croatian hiv-infected patients ...
2392889 - Genetic variance and heritability of serum cholesterol and triglycerides among chinese ...
3348759 - Dietary factors relate to cardiovascular risk factors in early life. bogalusa heart study.
11338699 - Lipid profiles in the isfahan population: an isfahan cardiovascular disease risk factor...
18006059 - Depuration kinetics and tissue disposition of pfoa and pfos in white leghorn chickens (...
19951409 - Dietary habits in three central and eastern european countries: the hapiee study.
8618149 - Dietary crude protein increases slightly the requirement for threonine in kittens.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta medica Indonesiana     Volume:  40     ISSN:  0125-9326     ISO Abbreviation:  Acta Med Indones     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2009-01-19     Completed Date:  2009-07-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7901042     Medline TA:  Acta Med Indones     Country:  Indonesia    
Other Details:
Languages:  eng     Pagination:  201-10     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital. Jalan Diponegoro no. 71, Jakarta Pusat 10430. idrus_a@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / blood*
Cholesterol, LDL / blood*
Curcumin / administration & dosage*
Double-Blind Method
Enzyme Inhibitors / administration & dosage*
Female
Humans
Intervention Studies
Male
Middle Aged
Treatment Outcome
Triglycerides / blood*
Chemical
Reg. No./Substance:
0/Cholesterol, LDL; 0/Enzyme Inhibitors; 0/Triglycerides; 458-37-7/Curcumin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polymorphism C3435T of The MDR-1 Gene Predict Response to Preoperative Chemotherapy in Locally Advan...
Next Document:  Malignant mesenterial mesothelioma in stroke patients.